Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1956 1
1957 2
1958 1
1960 2
1961 2
1963 1
1964 1
1968 2
1970 2
1971 1
1972 1
1974 1
1975 2
1976 1
1979 1
1983 1
1984 1
1985 1
1986 3
1987 2
1988 4
1989 2
1990 4
1991 4
1992 5
1993 8
1994 4
1995 11
1996 6
1997 4
1998 9
1999 8
2000 5
2001 12
2002 14
2003 12
2004 13
2005 24
2006 34
2007 35
2008 32
2009 28
2010 27
2011 19
2012 35
2013 25
2014 35
2015 49
2016 37
2017 42
2018 30
2019 46
2020 34
2021 51
2022 59
2023 56
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

761 results

Results by year

Filters applied: . Clear all
Page 1
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Herrera FG, Ronet C, Ochoa de Olza M, Barras D, Crespo I, Andreatta M, Corria-Osorio J, Spill A, Benedetti F, Genolet R, Orcurto A, Imbimbo M, Ghisoni E, Navarro Rodrigo B, Berthold DR, Sarivalasis A, Zaman K, Duran R, Dromain C, Prior J, Schaefer N, Bourhis J, Dimopoulou G, Tsourti Z, Messemaker M, Smith T, Warren SE, Foukas P, Rusakiewicz S, Pittet MJ, Zimmermann S, Sempoux C, Dafni U, Harari A, Kandalaft LE, Carmona SJ, Dangaj Laniti D, Irving M, Coukos G. Herrera FG, et al. Among authors: duran r. Cancer Discov. 2022 Jan;12(1):108-133. doi: 10.1158/2159-8290.CD-21-0003. Epub 2021 Sep 3. Cancer Discov. 2022. PMID: 34479871 Free PMC article.
Tumor response assessment on imaging following immunotherapy.
Berz AM, Dromain C, Vietti-Violi N, Boughdad S, Duran R. Berz AM, et al. Among authors: duran r. Front Oncol. 2022 Oct 25;12:982983. doi: 10.3389/fonc.2022.982983. eCollection 2022. Front Oncol. 2022. PMID: 36387133 Free PMC article. Review.
Glutamine, MTOR and autophagy: a multiconnection relationship.
Bodineau C, Tomé M, Murdoch PDS, Durán RV. Bodineau C, et al. Among authors: duran rv. Autophagy. 2022 Nov;18(11):2749-2750. doi: 10.1080/15548627.2022.2062875. Epub 2022 Apr 26. Autophagy. 2022. PMID: 35470752 Free PMC article.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R… See abstract for full author list ➔ Klionsky DJ, et al. Among authors: duran rv. Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 Feb 8. Autophagy. 2021. PMID: 33634751 Free PMC article.
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Barras D, Ghisoni E, Chiffelle J, Orcurto A, Dagher J, Fahr N, Benedetti F, Crespo I, Grimm AJ, Morotti M, Zimmermann S, Duran R, Imbimbo M, de Olza MO, Navarro B, Homicsko K, Bobisse S, Labes D, Tsourti Z, Andriakopoulou C, Herrera F, Pétremand R, Dummer R, Berthod G, Kraemer AI, Huber F, Thevenet J, Bassani-Sternberg M, Schaefer N, Prior JO, Matter M, Aedo V, Dromain C, Corria-Osorio J, Tissot S, Kandalaft LE, Gottardo R, Pittet M, Sempoux C, Michielin O, Dafni U, Trueb L, Harari A, Laniti DD, Coukos G. Barras D, et al. Among authors: duran r. Sci Immunol. 2024 Feb 2;9(92):eadg7995. doi: 10.1126/sciimmunol.adg7995. Epub 2024 Feb 2. Sci Immunol. 2024. PMID: 38306416
Proteotoxicity and Neurodegenerative Diseases.
Ruz C, Alcantud JL, Vives Montero F, Duran R, Bandres-Ciga S. Ruz C, et al. Among authors: duran r. Int J Mol Sci. 2020 Aug 6;21(16):5646. doi: 10.3390/ijms21165646. Int J Mol Sci. 2020. PMID: 32781742 Free PMC article. Review.
Cryoablation and immunotherapy of cancer.
Yakkala C, Denys A, Kandalaft L, Duran R. Yakkala C, et al. Among authors: duran r. Curr Opin Biotechnol. 2020 Oct;65:60-64. doi: 10.1016/j.copbio.2020.01.006. Epub 2020 Feb 20. Curr Opin Biotechnol. 2020. PMID: 32088576 Review.
Imaging assessment of toxicity related to immune checkpoint inhibitors.
Berz AM, Boughdad S, Vietti-Violi N, Digklia A, Dromain C, Dunet V, Duran R. Berz AM, et al. Among authors: duran r. Front Immunol. 2023 Feb 23;14:1133207. doi: 10.3389/fimmu.2023.1133207. eCollection 2023. Front Immunol. 2023. PMID: 36911692 Free PMC article. Review.
761 results